Telix Pharmaceuticals Ltd financial data

Symbol
TLX on Nasdaq, TLPPF on OTC
Location
North Melbourne, Australia
Fiscal year end
31 December
Latest financial report
20-F - Q4 2025 - 20 Feb 2026

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 338,777,049 shares 1.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill $198,988,000 USD 199%
Assets $1,163,986,000 USD 24%
Liabilities $748,610,000 USD 27%